histamine has been researched along with n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Auchampach, JA; Bolli, R; Maldonado, C; Qiu, Y; Rizvi, A; Tang, XL; Teschner, S | 1 |
| D'Agati, VD; Emala, CW; Jacobson, MA; Lee, HT; Ota-Setlik, A; Xu, H | 1 |
| Broadley, KJ; Martin, TJ | 1 |
| Ezeamuzie, CI; Philips, E | 1 |
| Galun, E; Matot, I; Rivo, J; Zeira, E | 1 |
| Alhaj, M; Bozarov, A; Christofi, FL; Cooke, HJ; Grants, I; Hassanain, HH; Ren, T; Wang, YZ; Wunderlich, J; Yu, JG | 1 |
6 other study(ies) available for histamine and n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine
| Article | Year |
|---|---|
Selective activation of A3 adenosine receptors with N6-(3-iodobenzyl)adenosine-5'-N-methyluronamide protects against myocardial stunning and infarction without hemodynamic changes in conscious rabbits.
Topics: Adenosine; Animals; Heart; Hemodynamics; Histamine; Male; Myocardial Infarction; Myocardial Stunning; Rabbits; Rats; Receptors, Purinergic P1 | 1997 |
A3 adenosine receptor knockout mice are protected against ischemia- and myoglobinuria-induced renal failure.
Topics: Acute Kidney Injury; Adenosine; Animals; Genotype; Histamine; Ischemia; Kidney; Mice; Mice, Inbred C57BL; Mice, Knockout; Myoglobinuria; p-Methoxy-N-methylphenethylamine; Purinergic P1 Receptor Agonists; Receptor, Adenosine A3; Receptors, Purinergic P1; Reference Values; Renal Circulation; Reperfusion Injury | 2003 |
Contractile responses to adenosine, R-PIA and ovalbumen in passively sensitized guinea-pig isolated airways.
Topics: Adenosine; Animals; Dose-Response Relationship, Drug; Guinea Pigs; Histamine; Immune Sera; In Vitro Techniques; Isotonic Solutions; Methacholine Chloride; Muscle Contraction; Ovalbumin; Purinergic P1 Receptor Agonists; Receptor, Adenosine A3; Time Factors; Trachea; Vasodilator Agents | 2002 |
Positive coupling of atypical adenosine A3 receptors on human eosinophils to adenylyl cyclase.
Topics: Adenosine; Adenylyl Cyclases; Adult; Cell Degranulation; Cyclic AMP; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Eosinophils; Histamine; Humans; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Quinazolines; Receptor, Adenosine A2A; Receptor, Adenosine A3; Receptors, Purinergic P1; Triazoles | 2003 |
Activation of A3 adenosine receptors attenuates lung injury after in vivo reperfusion.
Topics: Adamantane; Adenosine; Adenosine A3 Receptor Agonists; Adenosine A3 Receptor Antagonists; Animals; ATP-Binding Cassette Transporters; Cats; Dihydropyridines; Enzyme Inhibitors; Hemodynamics; Histamine; In Vitro Techniques; KATP Channels; Lung; Morpholines; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitroarginine; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Inwardly Rectifying; Pulmonary Artery; Reperfusion Injury | 2004 |
Activation of adenosine low-affinity A3 receptors inhibits the enteric short interplexus neural circuit triggered by histamine.
Topics: Adenosine; Animals; Chlorides; Cimetidine; Colon; Dihydropyridines; Dimaprit; Dose-Response Relationship, Drug; Enteric Nervous System; Gastrointestinal Motility; Guinea Pigs; Histamine; Histamine Agonists; Histamine H2 Antagonists; In Vitro Techniques; Intestinal Secretions; Male; Mecamylamine; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; Neural Inhibition; Neurogenic Bowel; Neurokinin-1 Receptor Antagonists; Nicotinic Antagonists; Piperidines; Propane; Receptor, Adenosine A1; Receptor, Adenosine A3; Receptors, Histamine H2; Receptors, Neurokinin-1; Reflex; Theophylline; Xanthines | 2009 |